During the past decade, Austin Cancer Centers-Central Austin conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Austin Cancer Centers-Central Austin" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 4 trials, followed by "National Cancer Institute (NCI)" with 2 trials sponsored, "Agendia" with 1 trials sponsored, "Aronex Pharmaceuticals" with 1 trials sponsored and "CTI BioPharma" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Cancer Centers-Central Austin" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Austin Cancer Centers-Central Austin" are "Breast Cancer" (3 trials), "Leukemia" (2 trials), "Adult Giant Cell Glioblastoma" (1 trials), "Adult Glioblastoma" (1 trials) and "Adult Gliosarcoma" (1 trials). Many other conditions were trialed in "Austin Cancer Centers-Central Austin" in a lesser frequency.

Most popular intervention types in "Austin Cancer Centers-Central Austin" are "Drug" (13 trials), "Other" (9 trials), "Radiation" (6 trials), "Biological" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (3 trials), "Placebo" (3 trials), "Quality-of-Life Assessment" (2 trials), "Questionnaire Administration" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Austin Cancer Centers-Central Austin" are 13 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Austin Cancer Centers-Central Austin". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Austin Cancer Centers-Central Austin, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Austin Cancer Centers-Central Austin, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Austin Cancer Centers-Central Austin has several departments that took part in Clinical trials: "Austin Cancer Centers-Northwest" - 2 trials